Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

stocks1

Weekly Movers: Lpath, Paratek, Inovio…

June 27, 2016 Research and Development, Sales and Marketing

Shares in Lpath (Nasdaq: LPTN) jumped 55% after the company said it has secured a two-year $1.45 million grant by …
Feature
china-pharmaceutical-industry

Brexit may also create opportunities for UK’s pharmaceutical and medical device industries – report

June 27, 2016 Research and Development, Sales and Marketing

Even though UK’s exit from the European Union undoubtedly creates significant issues for the UK pharmaceutical and medical device industries …
News
astellas_imageuk

Astellas UK suspended from ABPI for “deception” and other cultural failings

June 24, 2016 Medical Communications, Research and Development, Sales and Marketing ABPI, Astellas, cultural failings

Astellas UK has been suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for a period …
News

Nice rejects AstraZeneca’s Tagrisso for lung cancer in preliminary recommendation

June 24, 2016 Medical Communications, Research and Development AstraZeneca, CDF, NICE, lung cancer, regulation

UK drugmaker AstraZeneca (LSE: AZN) said the National Institute for Health and Care Excellence (Nice) has rejected Tagrisso (osimertinib) to …
News
brexit

“Immediate challenges” for UK pharma post-Brexit, says ABPI

June 24, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, brexit

The UK life sciences industry has expressed dismay at the result of the EU referendum, but has pledged to work …
News
allergan

FDA approves expanded label for Allergan’s Avycaz

June 24, 2016 Medical Communications, Research and Development, Sales and Marketing Allergan, Avycaz, FDA, expanded label

Allergan (NYSE: FDA) has announced that the US Food and Drug Administration (FDA) has approved its supplemental new drug application …
News
cancer

Genmab’s CLL drug gets negative opinion from EMA committee

June 24, 2016 Medical Communications, Research and Development, Sales and Marketing Arzerra, CHMP, CLL, EMA, Genmab, blood cancer

Genmab A/S (Nasdaq Copenhagen: GEN) said its drug Arzerra (ofatumumab) received a negative opinion by the Committee for Medicinal Products …
News
celgene_1_02

Nice rejects Celgene’s drug to treat blood cancer

June 24, 2016 Medical Communications, Research and Development CDF, Celgene, NICE, Vidaza, blood cancer

The National Institute for Health and Care Excellence (Nice) rejected biotech firm Celgene’s (Nasdaq: CELG) Vidaza (azacitidine) to treat a …
News
sanofi_hq__boetie_hall

Sanofi to add future payments onto Medivation offer, according to reports

June 23, 2016 Research and Development, Sales and Marketing Medivation, Sanofi

Sanofi (NYSE: SNY) is considering adding future payments, tied to certain targets, to its proposed $9.3 billion takeover of US …
News

Timely use of Novartis’ Entresto could prevent/delay over 28,000 US deaths a year – study

June 23, 2016 Research and Development, Sales and Marketing Entresto, JAMA Cardiology, Novartis, drug trial, research

A timely switch to Novartis’ (VTX: NOVN) heart failure drug Entresto (sacubitril/valsartan) in patients could prevent or delay more than …
News
humira_abbott_

New Humira data shows improved quality of life in ulcerative colitis patients

June 23, 2016 Research and Development AbbVie, Humira, data, ulcerative colitis

New data on Humira (adalimumab) has been presented at the British Society of Gastroenterology, demonstrating the drug’s efficacy and improvement …
News
gsk_l_rgb

Interview: GSK’s subcutaneous formulation for Benlysta may help cut down hospital visits

June 22, 2016 Research and Development Benlysta, EULAR, Interview, Lupus, NICE, autoimmune diseases, drug trial

UK drugmaker GlaxoSmithKine (LSE: GSK) reported positive results for Benlysta following a late-stage study at the annual European Congress of …
Feature
clinical_trial_3

Wave Life Sciences granted FDA orphan drug designation for Huntington’s disease drug

June 22, 2016 Research and Development FDA, drug, huntington's disease, wave life sciences

Wave Life Sciences (NASDAQ: WVE) has announced that it has received orphan drug designation for the US Food and Drug …
News
entrance_takeda_i020_v1

Takeda begins world’s first norovirus vaccine field trial

June 22, 2016 Research and Development Takeda, Vaccine, norovirus

Takeda Pharmaceuticals (TSE: 4502) has announced that the first patient has received a dosage of their norovirus vaccine candidate, TAK-214, …
News
stocks2

Immunomedics’ chief financial officer resigns, shares fall

June 22, 2016 Research and Development, Sales and Marketing Immunomedics, Shares, cfo, stock market

Shares in Immunomedics (Nasdaq: IMMU) fell as much as 11% after the company said its chief financial officer Peter Pfreundschuh …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026